Marquart Mary E, O'Callaghan Richard J
Department of Microbiology, University of Mississippi Medical Center, 2500 N. State Street, Jackson, MS 39216, USA.
J Ophthalmol. 2013;2013:369094. doi: 10.1155/2013/369094. Epub 2013 Jan 8.
Ocular bacterial infections are universally treated with antibiotics, which can eliminate the organism but cannot reverse the damage caused by bacterial products already present. The three very common causes of bacterial keratitis-Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus pneumoniae-all produce proteins that directly or indirectly cause damage to the cornea that can result in reduced vision despite antibiotic treatment. Most, but not all, of these proteins are secreted toxins and enzymes that mediate host cell death, degradation of stromal collagen, cleavage of host cell surface molecules, or induction of a damaging inflammatory response. Studies of these bacterial pathogens have determined the proteins of interest that could be targets for future therapeutic options for decreasing corneal damage.
眼部细菌感染通常使用抗生素进行治疗,抗生素可以消灭病原体,但无法逆转已经存在的细菌产物所造成的损害。细菌性角膜炎的三个非常常见的病因——铜绿假单胞菌、金黄色葡萄球菌和肺炎链球菌——都会产生蛋白质,这些蛋白质直接或间接对角膜造成损害,即使经过抗生素治疗,也可能导致视力下降。这些蛋白质中的大多数(但不是全部)是分泌性毒素和酶,它们介导宿主细胞死亡、基质胶原蛋白降解、宿主细胞表面分子裂解或引发有害的炎症反应。对这些细菌病原体的研究已经确定了一些值得关注的蛋白质,它们可能成为未来减少角膜损伤的治疗选择的靶点。